Applying Ethics and Integrity to Human Research
IntegReview reviews the following types of research: Phase I-IV drug/biomedical, medical device, social and behavioral, Investigator-sponsored, single and multiple investigator as well as research conducted in academic and hospital settings, expedited review for research that qualifies, expedited review of additional Investigators, research determined to be exempt, research conducted in Latin America and Canada.
IntegReview Ethical Review Board
3001 S. Lamar Blvd., Suite 210
Austin, TX 78704
Phone: 512-326-3001
Fax: 512-697-0085

Research Participant

As an Institutional Review Board (IRB), IntegReview’s responsibility is to assure the protection of the rights and welfare of the research participants.

As a research participant, IntegReview recommends that you ask and ensure you have answers to the following questions before deciding to participate in a research study:

  1. What is the main purpose of the study?
  2. Does the study involve a placebo (inactive treatment, equivalent to a sugar pill) or a treatment/device that is already on the market?
  3. How will the study drug/device be given to me?
  4. How long is the study going to last and what will I be asked to do as a participant?
  5. What has been learned about the study drug/device and are any study results published?
  6. Do I have to pay for any part of the study? Will my insurance cover these costs?
  7. Will I be able to see my own doctor?
  8. If the study drug/device works for me, can I keep using it after the study?
  9. Can anyone find out whether I’m participating in the research study?
  10. Will I receive any follow-up care after the study has ended?
  11. What will happen to my medical care if I stop participating in the study?
  12. Am I comfortable with the doctor and study staff as they will be medical care providers during the study?

Helpful Links regarding clinical research participation

Once you have completed participation in a research study, please feel free to complete IntegReview’s Research Participant Survey to offer any feedback on the informed consent document.

You may obtain answers to questions regarding your rights as a research subject by dialing our main office number at (512) 326-3001 or express concerns via e-mail to